Japanese life sciences company YMC Co Ltd has entered into a formal agreement to acquire Lewa-Nikkiso America Inc’s pharmaceutical systems business.
Based in Devens, Massachusetts, USA, the business provides advanced production scale chromatography systems for the bioprocessing and the pharmaceutical industry.
Lewa remains a key partner of the business through a long term pump supply arrangement. Lewa pumps are a basis for the EcoPrime LPLC, HPLC, SMB, Continuous Chromatography and BID systems.
“Lewa has a truly unique and differentiated positioning with its EcoPrime systems and strong awareness among end users, especially those pursuing continuous processing of pharmaceuticals and biopharmaceuticals,” said Ryuji Yamamura, CEO of YMC. “Through this acquisition, we will create the first American-based manufacturing for YMC. In addition, we believe that acquiring Lewa’s extensive experience in precision purification systems and automation for GMP scale equipment can unlock YMC’s mostly untapped growth potential for systems outside of Asia.”
“Lewa had great success in gaining industry recognition as an innovative purification systems player in the bioprocess space in a short period of time,” said Peter Castellanos, CEO of Lewa-Nikkiso America. “After being approached by YMC we realized their product portfolio is well positioned to take the next phase of growth for this group. We remain strategically aligned to this business through the supply of our pumps and we are committed to facilitating the seamless transition of the business to YMC. Existing customers should see no disruption in present production.”
